Načítá se...
Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins
1. Angiotensin II receptor blockers (AIIRBs) have been shown to prevent atrial fibrillation. The pulmonary veins (PVs) are the most important focus for the generation of atrial fibrillation. The aim of this study was to evaluate whether angiotensin II or AIIRB may change the arrhythmogenic activity...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2005
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1615848/ https://ncbi.nlm.nih.gov/pubmed/16273119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0706445 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|